Nigeria may experience some setback in its coronavirus
vaccine distribution as the Serum Institute of India (SII), the main supplier
of the COVAX facility, says it may not resume export of vaccine doses till the
end of 2021.
Nigeria is currently a beneficiary of the United Nations-led
COVAX facility which is facilitating the procurement of vaccines for African
countries.
In February 2021, COVAX had announced the donation of 16
million doses to Nigeria, although the country is currently distributing the
3.9 million doses supplied in March for the first phase of vaccination.
The AstraZeneca vaccine doses currently being distributed in the country are sourced from the SII.
Osagie Ehanire, minister of health, had said Nigeria is
expecting 58 million doses of COVID-19 vaccines from COVAX and African Union
AVATT platform, while Faisal Shuaib, executive director of the National Primary
Health Care Development Agency (NPHCDA), had said the country should receive
some vaccine doses via COVAX by the end of May or in June.
But in a statement on Tuesday, SII said it will focus on
boosting the vaccination drive for India as the country battles a major spike
in its infection rate.
As a result of the surge in India — the south Asian country
has recorded over 400,000 cases daily in recent times — several countries have
responded by sending aid in the form of medicines, oxygen concentrators and
ventilators.
According to SII, the decision to support other countries
was taken at a time when the daily cases recorded in India were low.
“In the past few days, there has been an intense discussion
on the decision of the government and Indian vaccine manufacturers, including
the Serum Institute of India (SII) to export vaccines,” the statement reads.
“In January 2021, we had a large stockpile of vaccine doses.
Our vaccination drive had started successfully and the number of daily cases
being recorded were at an all-time low.
“Around the same time, many other countries in the world
were facing an acute crisis and were in desperate need of help. Our government
extended support wherever possible during this period.
“We will not be safe
till everyone globally is able to defeat this virus at a global scale. Further,
as part of our global alliances, we also had commitments to COVAX, so that they
could distribute the vaccines globally to end the pandemic.
“SII has delivered more than 200 million doses, even though
we received EUA two months after the US pharma companies. If we look at total
doses produced and delivered, we rank amongst the top three in the world. We
continue to scale up manufacturing and prioritize India. We also hope to start
delivering to COVAX and other countries by the end of this year.”
Important Information pic.twitter.com/M1R1P6rqUp
— SerumInstituteIndia (@SerumInstIndia) May 18, 2021
However, Nigeria has explored other options outside India, with 29 million doses of the Johnson & Johnson vaccine expected through the African Union.
Click to signup for FREE news updates, latest information and hottest gists everydayAdvertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com